Reliant Pharmaceuticals

From Wikipedia, the free encyclopedia

Jump to: navigation, search

Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007.^[1]

It was known for six major products, including Omacor/Lovaza, Axid, and InnoPran XL a propranolol based beta blocker.

References [edit]

^ Reliant Redirect - GlaxoSmithKline

Pharmaceutical and biotechnology industry in the United Kingdom

Current	AAH Pharmaceuticals Alliance Boots Astex AstraZeneca (MedImmune) BTG Cyclacel Dechra Pharmaceuticals GE Healthcare Genus GlaxoSmithKline Hikma Pharmaceuticals Intercytex MacFarlan Smith Norbrook Group Oxford BioMedica Pfizer UK Phytopharm Proximagen Renovo Shire Silence Therapeutics TBS GB Unipath Vectura Group Vernalis ViiV Healthcare

Defunct	Allen & Hanburys Amersham plc Beecham Group Cambridge Antibody Technology Celltech Chiroscience Distillers Company Fisons Glaxo Wellcome Reliant Pharmaceuticals Zeneca

Government and
regulatory bodies

Industry and
professional bodies

Books and journals

Bandolier
Bad Pharma (2012)
British National Formulary
British National Formulary for Children

Other

Category

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.

Retrieved from "http://en.wikipedia.org/w/index.php?title=Reliant_Pharmaceuticals&oldid=540100380"